1
/
of
1
Elabscience
SKU:PKSV030152
Recombinant EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein / GP1 Protein (His Tag)
Recombinant EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein / GP1 Protein (His Tag)
Regular price
$855.00 USD
Regular price
Sale price
$855.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant EBOV (Subtype Zaire, Strain H.Sapiens-WT/GIN/2014/Kissidougou-C15) GP1 / Glycoprotein Protein (His Tag), a cutting-edge product designed to revolutionize the field of medical research and development. This meticulously engineered protein, boasting a His Tag, offers unparalleled potential for advancing our understanding of the Ebola virus and its associated pathogenicity.
Crafted with utmost precision, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) is derived from the Zaire subtype, specifically the H.Sapiens-WT/GIN/2014/Kissidougou-C15 strain. This strain has been carefully selected for its relevance and significance in the study of Ebola virus infections in humans.
The inclusion of the His Tag in this recombinant protein further enhances its utility and versatility. The His Tag facilitates efficient purification and detection of the protein, enabling researchers to streamline their experimental procedures and obtain accurate results with ease.
With its exceptional purity and stability, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) serves as an invaluable tool for various applications, including but not limited to vaccine development, diagnostic assay development, and therapeutic research. Its high affinity for binding to specific receptors on host cells allows for comprehensive investigations into the mechanisms of viral entry and infection.
Furthermore, this product adheres to the highest quality standards, ensuring reproducibility and reliability in experimental settings. Each batch undergoes rigorous quality control measures to guarantee consistency and optimal performance, instilling confidence in researchers and scientists alike.
In summary, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) represents a breakthrough in the field of Ebola virus research. Its unique composition, derived from the Zaire subtype and featuring a His Tag, offers unprecedented opportunities for advancing our knowledge and combating this deadly pathogen. Embrace this remarkable tool and unlock new possibilities in the fight against Ebola.
Crafted with utmost precision, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) is derived from the Zaire subtype, specifically the H.Sapiens-WT/GIN/2014/Kissidougou-C15 strain. This strain has been carefully selected for its relevance and significance in the study of Ebola virus infections in humans.
The inclusion of the His Tag in this recombinant protein further enhances its utility and versatility. The His Tag facilitates efficient purification and detection of the protein, enabling researchers to streamline their experimental procedures and obtain accurate results with ease.
With its exceptional purity and stability, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) serves as an invaluable tool for various applications, including but not limited to vaccine development, diagnostic assay development, and therapeutic research. Its high affinity for binding to specific receptors on host cells allows for comprehensive investigations into the mechanisms of viral entry and infection.
Furthermore, this product adheres to the highest quality standards, ensuring reproducibility and reliability in experimental settings. Each batch undergoes rigorous quality control measures to guarantee consistency and optimal performance, instilling confidence in researchers and scientists alike.
In summary, the Recombinant EBOV GP1 / Glycoprotein Protein (His Tag) represents a breakthrough in the field of Ebola virus research. Its unique composition, derived from the Zaire subtype and featuring a His Tag, offers unprecedented opportunities for advancing our knowledge and combating this deadly pathogen. Embrace this remarkable tool and unlock new possibilities in the fight against Ebola.
Share
